Zobrazeno 1 - 10
of 1 095
pro vyhledávání: '"cteph"'
Autor:
Noha Rami Ismail, Hamdy A. Makhlouf, Atef Hassan, Ahmed Elshahat, Mohamed Abdelfatah Abdellatif, Abdelmoemen Esam Rezk, Abdelrahman Mady, Rashad G. Mohamed, Hanady Mohammad Elfeky, Ahmed Abdelaziz
Publikováno v:
American Heart Journal Plus, Vol 46, Iss , Pp 100466- (2024)
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a major risk for pulmonary hypertension with poor prognosis. Limited data is available on the optimal treatment of choice. We aimed to comprehensively assess the efficacy and safety
Externí odkaz:
https://doaj.org/article/0e1fc50558e64b1b93f28a3f7b0df6b2
Autor:
Beatrice Simeone, Enrico Maggio, Leonardo Schirone, Erica Rocco, Gianmarco Sarto, Luigi Spadafora, Marco Bernardi, Luca D’ Ambrosio, Maurizio Forte, Daniele Vecchio, Valentina Valenti, Sebastiano Sciarretta, Carmine Dario Vizza
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) presents a significant diagnostic challenge due to its complex and often nonspecific clinical manifestations. This review outlines a comprehensive approach to the diagnostic assessment of CTEPH, e
Externí odkaz:
https://doaj.org/article/8636b5108e1d485fa2e0897feadf7467
Autor:
Beatrice Simeone, Enrico Maggio, Leonardo Schirone, Erica Rocco, Gianmarco Sarto, Luigi Spadafora, Marco Bernardi, Luca D’Ambrosio, Maurizio Forte, Daniele Vecchio, Valentina Valenti, Sebastiano Sciarretta, Carmine Dario Vizza
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a severe and complex condition that evolves from unresolved pulmonary embolism, leading to fibrotic obstruction of pulmonary arteries, pulmonary hypertension, and potential right heart failure.
Externí odkaz:
https://doaj.org/article/a178a3f6d8e54855976749e0dadffd24
Publikováno v:
Life, Vol 14, Iss 10, p 1265 (2024)
Pulmonary hypertension (PH) is a severe and chronic disease characterized by increased pulmonary vascular resistance and remodeling, often precipitating right-sided heart dysfunction and death. Although the condition is progressive and incurable, cur
Externí odkaz:
https://doaj.org/article/d91b094975094067a1685931e192ab6a
Publikováno v:
Frontiers in Surgery, Vol 11 (2024)
BackgroundNew-onset postoperative atrial fibrillation (POAF) is a common complication after pulmonary thromboendarterectomy (PEA), yet the risk factors and their impact on prognosis remain poorly understood. This study aims to investigate the risk fa
Externí odkaz:
https://doaj.org/article/0259460a559141c79854e3dc244f91af
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract Pulmonary arterial hypertension (PAH) is driven by pathologies associated with increased metabolism such as pulmonary revascularization, vasoconstriction and smooth muscle cell proliferation in pulmonary artery wall. 18‐fluorodeoxyglucose
Externí odkaz:
https://doaj.org/article/c6824e814a9b4140b36182a79f71f1ed
Autor:
Lojain Abdulaal, Ahmed Maiter, Mahan Salehi, Michael Sharkey, Turki Alnasser, Pankaj Garg, Smitha Rajaram, Catherine Hill, Christopher Johns, Alex Matthew Knox Rothman, Krit Dwivedi, David G. Kiely, Samer Alabed, Andrew James Swift
Publikováno v:
Frontiers in Radiology, Vol 4 (2024)
BackgroundChronic pulmonary embolism (PE) may result in pulmonary hypertension (CTEPH). Automated CT pulmonary angiography (CTPA) interpretation using artificial intelligence (AI) tools has the potential for improving diagnostic accuracy, reducing de
Externí odkaz:
https://doaj.org/article/b535f80e113f4662891fd5d96333ce2f
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a form of pulmonary hypertension with a high mortality rate. A new type of iron-mediated cell death is Ferroptosis, which is characterized by the accumulation of lethal iron
Externí odkaz:
https://doaj.org/article/8b72b6f6efa647b19a32d48c3a8d7744
Publikováno v:
Tomography, Vol 9, Iss 5, Pp 1787-1798 (2023)
CT pulmonary angiography is commonly used in diagnosing chronic thromboembolic pulmonary hypertension (CTEPH). This work was conducted to determine if cardiac chamber size on CTPA may also be useful for predicting the outcome of CTEPH treatment. A re
Externí odkaz:
https://doaj.org/article/13e5f40b0bab4d2c9dc440b4e1e5b87a
Publikováno v:
Patient Preference and Adherence, Vol Volume 17, Pp 2119-2130 (2023)
Beenish Nafees,1 Hayley M de Freitas,1 Amélie Beaudet,2 Eunju Todd,3 Wendy Gin-Sing4 1Patient-Reported Outcomes, Nafees Consulting Limited, London, UK; 2Global Market Access and Pricing, Actelion Pharmaceuticals Ltd, Allschwil, Switzerland; 3Janssen
Externí odkaz:
https://doaj.org/article/a7f69a6399ff4bb6a9bd9d09437da901